VRC-3885
Chemical Name: N-[3-[3-Fluoro-4-(1-oxothiomorpholin-4-yl)phenyl]-2-oxooxazolidin-5(S)-ylmethyl]-3-[4-(methoxyiminomethyl)phenyl]-2-propenamide
项目整合开发状态: Biological Testing
项目研究机构: Vicuron Pharmaceuticals (Originator)
合成路线:The title compound is prepared by solid phase synthesis utilizing a chloro-derivatized Sasrin resin.Coupling of aminomethyl oxazolidinone (I) to the chloromethyl resin affords the amine bound resin (II).This is then acylated with the cinnamic acid derivative (III) by means of HATU to furnish the corresponding amide (IV).Finally,cleavage of the target amide from resin (IV) is effected by treatment with 10% trifluoroacetic acid in CH2Cl2.
📌 参考资料/链接:
参考文献标题:Combinatorial lead optimization of oxazolidinones: In vitro activity of novel 5-amidomethyl thiomorpholine S-oxide and S,S-dioxide phenyloxazolidiones
文献作者:Zhou,J.; et al.
参考来源:42nd Intersci Conf Antimicrob Agents Chemother (Sept 27 2002,San Diego) 2002,Abst F-1319